Effect of intestinal preparation on the efficacy and safety of fecal microbiota transplantation treatment
10.3760/cma.j.cn.441530-20200418-00225
- VernacularTitle:不同肠道准备方式对菌群移植疗效及安全性的影响
- Author:
Qiyi CHEN
1
;
Hongliang TIAN
;
Bo YANG
;
Zhiliang LIN
;
Di ZHAO
;
Chen YE
;
Xueying ZHANG
;
Huanlong QIN
;
Ning LI
Author Information
1. 同济大学附属第十人民医院结直肠病专科 肠道微生态诊疗中心，上海 200072
- Keywords:
Fecal microbiota transplantion;
Intestinal preparation;
Antibiotics
- From:
Chinese Journal of Gastrointestinal Surgery
2020;23(Z1):48-55
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effect of intestinal preparation on the efficacy and complications of fecal microbiota transplantation (FMT).Methods:A retrospective cohort study was performed. Clinical and follow-up data of 1501 patients who received FMT in the department of Colorectal Disease Specialty, Intestinal Microecology Diagnosis and Treatment Center, the Tenth People′s Hospital, Tongji University from February 2018 to June 2019 were collected retrospectively. According to the intestinal preparation before FMT treatment, patients were divided into non-intestinal preparation group ( n=216), antibiotic pretreatment group ( n=383), intestinal cleansing group ( n=267), and antibiotic combined with intestinal cleansing group ( n=635). The adverse reactions after FMT treatment and the effective rates at 4-week and 8-week after treatment among the groups were compared. Patients, who repeated FMT treatment in the 3rd month and the 6th month due to reduced efficacy or ineffectiveness were divided into two subgroups: without intestinal preparation group and with intestinal preparation group. The effective rates of the two subgroups were compared. Results:Of the 1501 cases, 588 were male and 913 were female with mean age of (43.3±13.7) years and body mass index of (20.2±2.1) kg/m 2. Transplantation course was (3.3±1.7) weeks. The underlying diseases mainly included constipation ( n=564), Crohn's disease ( n=157), ulcerative colitis ( n=142), irritable bowel syndrome ( n=158), recurrent C. difficile infection (CDI) ( n=106), autism ( n=84), radiation intestinal injury ( n=133), radiation enteritis ( n=133), and non-CDI chronic diarrhea ( n=60); the remaining cases ( n=155). Baseline data among the 4 groups were not significantly different (all P>0.05). The overall morbidity of complication was 31.1% (467/1501), including 41 cases of vomiting (2.7%), 91 of nausea (6.1%), 49 of diarrhea (3.3%), 41 of abdominal pain (2.7%), 79 of bloating (5.3%), 72 of throat pain (4.8%), 38 of dizziness (2.5%), 51 of fever (3.4%), 3 of pulmonary infection (0.2%) and 2 of intestinal infection (0.1%). The above symptoms disappeared after symptomatic treatment. There was no statistically significant difference in the incidence of adverse reactions among the 4 groups ( P>0.05). After 4-week of FMT treatment, the overall effective rate was 63.5% (902/1420); the effective rate of non-intestinal preparation group, antibiotic pretreatment group, intestinal cleaning group, and antibiotic combined with intestinal cleansing groupwas 57.6% (114/198), 64.2% (231/360), 60.2% (154/265) and 66.5% (403/606), respectively, with no statistically significant difference (χ 2=6.659, P=0.084). After 8-week of FMT treatment, the overall effective rate was 61.3% (729/1293); the effective rate of non-intestinal preparation group, antibiotic pretreatment group, intestinal cleaning group, and antibiotic combined with intestinal cleansing group was 54.0% (88/163), 62.2% (202/325), 57.4% (132/230) and 64.4% (370/575), respectively, with no statistically significant difference (χ 2=13.620, P=0.003). The effective rates of antibiotic combined with intestinal cleansing group and antibiotic pretreatment group were obviously higher than that of non-intestinal preparation group (χ 2=5.789, P=0.016; χ 2=10.117, P=0.001). Subgroup analysis showed that in the third month, the effective rate at 4-week after treatment was 60.1% (184/306) in the without intestinal preparation group and 61.5% (115/187) in the with intestinal preparation group, whose difference was not significant (χ 2=0.091, P=0.763); however, in the sixth month, the effective rate at 4-week after treatment was 51.4% (89/173) in the without intestinal preparation group and 61.2% (161/263) in the with intestinal preparationgroup, whose difference was significant (χ 2=4.229, P=0.040). Conclusions:FMT treatment is safe and effective. The combination of antibiotics and intestinal cleaning can improve overall efficacy of FMT. For patients who need repeated FMT treatment, the combination of antibiotics and intestinal cleaning program within 3 months has no significant effect on the effective rate, but in the sixth month, combinedpreparation is necessary.
